ARCHIVES

Under A Flat Budget, NIH Suspends Grant Increases, May restore Funds Later.

This article is from The Cancer Letter archive.

Vol. 26 No. 43 | November 24, 2000

Download PDF Visit The Full Archive

Related Articles

Zevalin Regimen Effective In Mantle Cell Lymphoma

January 30, 2004

CHOP Evolution Remains Touchy Issues; Contractors Say NCI Plan Too Burdensome

April 22, 1983

Report Questions Effectiveness Of Bimanual Pelvic Exam

March 31, 2006

NCI Objects To Fisher As Scientific Director Of NSABP, Threatens To Cut Off Funding

May 6, 1994

In Vote Against Tarceva As Maintenance, ODAC Seeks Stronger Survival Benefit

December 18, 2009

Merck Serono Cancels Tecemotide Program In NSCLC, Including Two Phase III Trials

September 26, 2014